Central Region, Central, Singapore The company was established in Asia in Singapore. The main department of described VC is located in the Singapore.
Besides them, we counted 4 critical employees of this fund in our database.
The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. This BioVeda Capital works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2002. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from BioVeda Capital is 5-10 millions dollars. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioVeda Capital, startups are often financed by Zillionize Angel, University of Manchester, TA Ventures. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Yasuda Enterprise Development, Vertex Ventures Southeast Asia & India. In the next rounds fund is usually obtained by Sagamore Bioventures, Openspace Ventures, Morningside Group.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Employee Benefits, Financial Services. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight ASLAN Pharmaceuticals, MerLion Pharma, CXA Group. For fund there is a match between the location of its establishment and the land of its numerous investments - Singapore.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Breeze Ventures | Edison, New Jersey, United States |
| Cane Investment Partners | Chicago, Illinois, United States |
| Capital Alliance Corporation | Dallas, Texas, United States |
| Cingular Wireless | Brockhagen, Germany, Nordrhein-Westfalen |
| Greater Manchester Investment Fund | England, Manchester, United Kingdom |
| HosenCare Brothers | - |
| Interaction Ventures | Canada, Montréal, Quebec |
| West Corner Company | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sensely | $8M | 14 Feb 2017 | San Francisco, California, United States | ||
CXA Group | $8M | 09 Jan 2015 | Central | ||
ASLAN Pharmaceuticals | $22M | 10 Oct 2013 | Singapore, Central Region, Singapore | ||
Biolidics | $6M | 13 Mar 2013 | Central | ||
ASLAN Pharmaceuticals | $12M | 20 Jul 2011 | Central Region | ||
Idun Pharmaceuticals | $27M | 15 Jun 2004 | San Diego, California, United States | ||
Inspired Capital plc | $2M | 31 Jan 2003 | Bristol, England, United Kingdom | ||
MerLion Pharma | $13M | 30 Oct 2002 | Singapore, Singapore | ||
Renovis | $34M | 10 Jan 2002 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sensely | $8M | 14 Feb 2017 | San Francisco, California, United States | ||
CXA Group | $8M | 09 Jan 2015 | Central | ||
ASLAN Pharmaceuticals | $22M | 10 Oct 2013 | Singapore, Central Region, Singapore | ||
Biolidics | $6M | 13 Mar 2013 | Central | ||
ASLAN Pharmaceuticals | $12M | 20 Jul 2011 | Central Region | ||
Idun Pharmaceuticals | $27M | 15 Jun 2004 | San Diego, California, United States | ||
Inspired Capital plc | $2M | 31 Jan 2003 | Bristol, England, United Kingdom | ||
MerLion Pharma | $13M | 30 Oct 2002 | Singapore, Singapore | ||
Renovis | $34M | 10 Jan 2002 | South San Francisco, California, United States |
